Background illustration for clinical trials search

Paid Clinical Trials Orlando

Discover 1,006 paid clinical trials in Orlando, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma

for
Neuroblastoma
Location: Orlando FL, Gainesville FL, Miami FL, Charleston SC,
Sponsor: Giselle Sholler

Sex: All

Age: 1 - 21

Code: NCT05489887

Phase2, Recruiting

A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma

for
Basal Ganglia Germinoma, Diabetes Insipidus, Germinoma,
Location: Orlando FL, Tampa FL, St. Petersburg FL,
Sponsor: Children's Oncology Group

Sex: All

Age: 3 - 29

Code: NCT06368817

Phase2, Recruiting

National Collaborative to Improve Care of Children With Complex Congenital Heart Disease

for
Hypoplastic Left Heart Syndrome (HLHS)
Location: Orlando FL, St. Petersburg FL, Gainesville FL, Miami FL,
Sponsor: Children's Hospital Medical Center, Cincinnati

Sex: All

Age: 0 - 1

Code: NCT02852031

Recruiting

A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma

for
Cardiovascular Disorder, Classic Hodgkin Lymphoma,
Location: Orlando FL, Tampa FL, Jacksonville FL, Fort Myers FL,
Sponsor: Children's Oncology Group

Sex: All

Age: 7+

Code: NCT05705531

Recruiting

Ferric Citrate and Chronic Kidney Disease in Children

for
Chronic Kidney Diseases
Location: Orlando FL, Atlanta GA, Cincinnati OH, Columbus OH,
Sponsor: University of California, Los Angeles

Sex: All

Age: 6 - 18

Code: NCT04741646

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

HCRN Endoscopic Versus Shunt Treatment of Hydrocephalus in Infants

for
Hydrocephalus
Location: Orlando FL, Jacksonville FL, Birmingham AL,
Sponsor: University of Utah

Sex: All

Age: 0 - 2

Code: NCT04177914

Phase3, Recruiting

Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma

for
Neuroblastoma
Location: Orlando FL, Miami FL, Durham NC, Nashville TN,
Sponsor: Giselle Sholler

Sex: All

Age: 1 - 21

Code: NCT06540963

Phase2, Recruiting

Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma

for
Medulloblastoma
Location: Orlando FL, Tampa FL, Memphis TN, Houston TX,
Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 0 - 4

Code: NCT05535166

Phase2, Recruiting

Patiromer for Treatment of Hyperkalaemia in Children Under 12 Years of Age

for
Hyperkalemia
Location: Orlando FL, Miami FL, Augusta GA, Durham NC,
Sponsor: Vifor Pharma, Inc.

Sex: All

Age: 0 - 11

Code: NCT05766839

Phase2, Recruiting

Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors

for
Neuroblastoma, Ewing Sarcoma, Osteosarcoma, Rhabdomyosarcoma,
Location: Orlando FL, Tampa FL, St. Petersburg FL, Gainesville FL,
Sponsor: Milton S. Hershey Medical Center

Sex: All

Age: 0 - 30

Code: NCT06541262

Phase1, Phase2, Recruiting

A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)

for
Stage I Mixed Cell Type Kidney Wilms Tumor,
Location: Orlando FL, Tampa FL, St. Petersburg FL, Gainesville FL,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 30

Code: NCT06401330

Phase3, Recruiting

DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma

for
Medulloblastoma
Location: Orlando FL, Tampa FL, St. Petersburg FL, Miami FL,
Sponsor: Giselle Sholler

Sex: All

Age: 0 - 21

Code: NCT04696029

Phase2, Recruiting

Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas

for
Atypical Teratoid/Rhabdoid Tumor,
Location: Orlando FL, Tampa FL, Gainesville FL, Miami FL,
Sponsor: Milton S. Hershey Medical Center

Sex: All

Age: 0 - 26

Code: NCT06465199

Phase1, Phase2, Recruiting

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

for
Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia
Location: Orlando FL, Tampa FL, St. Petersburg FL, Gainesville FL,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 1 - 30

Code: NCT04546399

Phase2, Recruiting

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

for
Malignant Glioma
Location: Orlando FL, Tampa FL, St. Petersburg FL,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 1 - 21

Code: NCT05099003

Phase1, Phase2, Recruiting

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

for
B Acute Lymphoblastic Leukemia
Location: Orlando FL, Tampa FL, St. Petersburg FL, Gainesville FL,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 1 - 46

Code: NCT06124157

Phase2, Recruiting

A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis

for
Recurrent Langerhans Cell Histiocytosis,
Location: Orlando FL, Tampa FL, St. Petersburg FL, Gainesville FL,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0 - 22

Code: NCT05828069

Phase2, Recruiting

A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/Latina Adolescent and Young Adult Childhood Cancer Survivors, Walking Juntos Study

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Orlando FL, Tampa FL, St. Petersburg FL,
Sponsor: Children's Oncology Group

Sex: All

Age: 15 - 20

Code: NCT06410209

Phase2, Recruiting

A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)

for
Stage II Nasopharyngeal Carcinoma AJCC v8,
Location: Orlando FL, Tampa FL, Gainesville FL, Jacksonville FL,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0 - 21

Code: NCT06064097

Phase2, Recruiting

Pediatric Precision Laboratory Advanced Neuroblastoma Therapy

for
Neuroblastoma
Location: Orlando FL, Tampa FL, Miami FL, Charleston SC,
Sponsor: Giselle Sholler

Sex: All

Age: 0 - 22

Code: NCT02559778

Phase2, Recruiting

Orlando, Florida has a well-developed healthcare system with several prominent medical research facilities, making it an important hub for a diverse array of clinical trials. Notable institutions such as the Orlando Health Cancer Institute and the University of Central Florida's College of Medicine are at the forefront of these research initiatives.

Each medical center in Orlando focuses on innovative studies across various fields, including oncology, cardiovascular health, and neurological disorders, positioning Orlando as a vital contributor in advancing medical research and treatment options.

Why choose Orlando for clinical trials?

Orlando offers a vast array of advantages for individuals considering participation in clinical trials. The city is home to a diverse population, which helps create a wide range of participants, enhancing the reliability and applicability of research findings.

Additionally, Orlando’s thriving healthcare ecosystem fosters an environment of innovation and collaboration, with a strong emphasis on advancing medical research and treatment. By participating in a clinical trial in Orlando, participants not only gain access to innovative therapies but also play a crucial role in advancing scientific knowledge.

Common conditions studied in Orlando

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Orlando